SJS Investment Consulting’s ANI Pharmaceuticals ANIP Stock Holding History

SJS Investment Consulting’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74K	Buy	+21	New	+$1.69K	﹤0.01%	1833

Other funds holding ANIP

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK) London, United Kingdom $215M AUM 47.21% 1-Year Est. Return

SJS Investment Consulting's ANIP Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 21 shares worth $1.74K. The stake represents ﹤0.01% of the portfolio and ranks #1833 among its holdings.

58 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

SJS Investment Consulting held 21 shares of ANI Pharmaceuticals worth $1.74K as of Q2 2026.
ANI Pharmaceuticals was a new SJS Investment Consulting position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1833 holding.
58 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.